🇺🇸 FDA
Pipeline program

Imx-110

IMX-110-001

Phase 2 small_molecule active

Quick answer

Imx-110 for Solid Tumor, Adult is a Phase 2 program (small_molecule) at Immix Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Immix Biopharma
Indication
Solid Tumor, Adult
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials